Key facts
- medimo’s last known valuation is $4.3M (Jan 2025).
- It has raised $1.1M; the latest was Merger/Acquisition in Feb 2026.
- Status: Acquired/Merged (Operating Subsidiary).
- ·Watchlist + deal alerts for medimo
- ·The full record, as it builds
Funding rounds
No funding rounds for medimo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About medimo
Developer of an artificial intelligence tool designed to create medical record manuscripts from medical audio. The company tool automatically generates medical records in subjective, objective, assessment, and plan formats using audio input of consultation conversations and artificial intelligence summaries, enabling doctors to concentrate on their work.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2022
- Employees
- 20
- Website
- corp.medimo.ai/
- Ownership
- Acquired/Merged (Operating Subsidiary)
medimo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in medimo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on medimo in its N-PORT filings yet. We sweep new filings monthly.